Business Wire

Bluehole Publishes an Industry Comment on BAT 2021 Preliminary Results

Share

China’s leading vaping media, Bluehole New Consumption, today publishes an industry comment on BAT 2021 Preliminary Results

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220217005051/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Vuse US Value Share (Graphic: Business Wire)

Here below is the full article in English:

By February 15, the 4 major tobacco companies, including British America Tobacco(BAT), Altria, Philip Morris International and Japan Tobacco International, have announced their 2021 full-year results. BAT reported a revenue of £25.68 billion ($34.82 billion), a 6.9% increase in 2021, being the top among the four major tobacco companies in revenue.

BAT's revenue rise is also largely driven by the strong sales growth of new tobacco products, including vapor, heated tobacco and oral products.

In 2021, BAT recorded an "accelerating New Category revenue growth" of 50.9%, with 59% revenue surge in vapor products. By the end of 2021, there are more than 18.3 million adult consumers using BAT non-combustible products, with over 8.4 million vapers around the world.

"Continued growth in new categories is a cornerstone of BAT's long-term plans for success," said Ross Hindle, analyst at Third Bridge. "With over 1.1 billion smokers still using combustibles, the opportunity to convert consumers towards New Categories is highly attractive."

Committed to building a better tomorrow, BAT has been transforming its business by providing a variety of reduced-risk products. It is expected to reach the business targets of £5 billion revenue in New Categories products by 2025 and 50 million global consumers of non-combustible products by 2030. In 2021, BAT converted over 4.8 million adult smokers to non-combustible products, such as its vapor brand Vuse.

In September 2021, BAT announced that Vuse has become the number one global vaping brand. Since 2018, Vuse has witnessed a steady growth in global market share, as it partnered with SMOORE, a global leader in atomization technology. By virtue of its FEELM ceramic coils, SMOORE accounted for 18.9% of the total global market share in 2020. FEELM, the atomization tech brand belonging to SMOORE, has been the strategic provider of technology and manufacturing of Vuse.

As a global vapor leader, Vuse reached a full year value share of 33.5% in the top five vapor markets (the U.S, Canada, France, Germany and the UK), which account for approximately 75% of total industry vapor revenue (closed-system).

In the most important market, Vuse has continued its growth momentum in the U.S., as it closed 27% value share point gap in 2 years. With market leadership in 27 out of 50 states, Vuse's U.S. value share reached 35.9% in December 2021. With only 0.1% value share difference with Juul(36%), Vuse is about to be the leader in the U.S. market.

BAT announced its business transformation to build a better tomorrow, and it has been actively encouraging smokers to switch to reduced risk products. Meanwhile, Vuse has developed third-party age verification processes for online sales and worked with retail partners to ensure their products are only available to adult consumers. However, Juul is stuck in controversy, accused of marketing to minors in the U.S. In 2021, Juul agreed to pay $40 million to the state of North Carolina and $14.5 million to the state of Arizona to settle lawsuits over youth marketing.

In terms of atomization coil, Juul is still using traditional cotton coils while Vuse’s flagship product, Vuse Alto is one of the first major vapor products adopting FEELM ceramic coils, which have largely improved harm reduction performance and quality. As a driving force of growth, Vuse Alto accounted for over 90% of Vuse revenues in the U.S. in 2021.

Moreover, the U.S. Food and Drug Administration (FDA) authorized the sales of the first vape in the U.S, Vuse Solo in October 2021, and underscored its public health benefits and scientific substantiation, thereby significantly boosting Vuse's consumer recognition and Q4 sales in the U.S. It also sends positive message to the approval of other Vuse products, such as Vuse Alto, its flagship vapor product equipped with ceramic coils. The Premarket Tobacco Application (PMTA) of Vuse Alto was submitted a year after Vuse Solo.

According to Daiwa Securities, Vuse is superior to Juul for it is the first vapor brand to receive the marketing authorization from the U.S. FDA. It is likely that Vuse Alto will be approved for sales by the FDA as well, underpinned by years of scientific research of BAT and its technology provider SMOORE.

The following are the links to access BAT 2021 preliminary results:

https://www.bat.com/group/sites/UK__9D9KCY.nsf/vwPagesWebLive/DOCBHNFN/$file/FY_2021_Presentation_Slides.pdf

https://www.bat.com/group/sites/UK__9D9KCY.nsf/vwPagesWebLive/DOCBHNFN/$file/FY_2021_Announcement.pdf

To read the original article, please visit: https://bluehole.com.cn/news/detail/48439

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Bluehole New Consumption
Cheng Bianji, (86)13530848319

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Making Science Unveils ‘AWAKE’: The AI Venture Studio Industrialising Startup Creation and AI-First Innovative Solutions23.12.2025 20:51:00 CET | Press Release

Making Science, the global digital acceleration consultancy, today announced the launch of AWAKE Venture Studio. This "AI-first" model represents a new era in systematic innovation, designed to identify, prototype, and scale both internal proprietary solutions and independent AI-native startups with global reach. The launch of AWAKE is motivated by the significant efficiency gains of orders of magnitude that Making Science has already achieved through the internal integration of AI. By applying these methods, the firm has achieved a 2x acceleration in tech feature development reducing time in the deployment of AI Agents. This model has already proven its commercial and innovative power through the acceleration of startups like ad-machina, which has multiplied its value by 10 since joining the Making Science ecosystem. These proven benchmarks serve as the technical foundation for AWAKE’s two interconnected engines, which formalise this efficiency into a repeatable manufacturing process

FDA Clears First Extended Depth of Focus Contact Lens for Presbyopia23.12.2025 18:07:00 CET | Press Release

The Cataltheia Group and its U.S. subsidiary, Bruno Vision Care LLC, a leader in eye health innovation, today announced that the U.S. Food and Drug Administration (FDA) has cleared the first and only Daily Disposable Soft (Hydrophilic) Contact Lens for Presbyopia utilizing patented Extended Depth of Focus (EDOF) optical design technology, enabling commercial distribution in the United States. Deseyne® delivers smooth, continuous focus across near, intermediate, and distance vision, providing clear, natural vision without compromise. This performance is enabled by Cataltheia’s patented hyper-refractive central zone, engineered to precisely redirect light in a controlled manner. The result is a clear clinical advantage over the only other available contact lens option for presbyopia, multifocal lenses, which rely on multiple optical zones and often require prolonged visual and cognitive adaptation. “We are proud to offer the first contact lens solution for the world’s aging population th

Aramco Awards SLB Long-Term Contract to Support Kingdom’s Unconventional Gas Production Growth23.12.2025 14:58:00 CET | Press Release

Global technology company SLB (NYSE: SLB) has been awarded a five-year contract by Aramco to provide stimulation services for its unconventional gas fields. This award is part of a broader multi-billion contract, supporting one of the largest unconventional gas development programs globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251223074948/en/ The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconventional gas resources. The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconventional gas resources — a cornerstone of the Kingdom’s strategy to diversify its energy portfolio and support the global energy transition. “This agreement is an important step forward in Aramco’s effor

Tabelog, Japan's Largest (*1) Restaurant Search and Reservation Service, Launches Multilingual App for International Visitors23.12.2025 14:00:00 CET | Press Release

Tabelog (https://tabelog.com/en/), Japan's largest restaurant search and reservation service operated by Kakaku.com, Inc., launched its multilingual smartphone application (iOS/Android) for international travelers on Monday, November 17, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251221963753/en/ The Tabelog Multilingual App for International Travelers — Japan's Largest Restaurant Search and Reservation Service With approximately 100 million monthly users(*3), Tabelog is Japan's premier service widely used by Japanese locals for daily restaurant discovery. Its database is unrivaled domestically, featuring information on approximately 890,000 establishments nationwide and over 85 million reviews and photos(*4). Unlike global map services or travel sites, Tabelog is built on "authentic ratings and reviews from local Japanese users," enabling travelers to discover truly exceptional restaurants beloved by locals — not

BeOne Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference23.12.2025 12:01:00 CET | Press Release

BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, with a presentation at 7:30 am PST. Live webcasts of these events can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com, https://hkexir.beonemedicines.com, https://sseir.beonemedicines.com. Archived replays will be available on the Company’s website. About BeOne Medicines BeOne Medicines is a global oncology company based in Switzerland that is discovering and developing innovative treatments that are more accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of nearly 12,000 colleagues spanning six continents, the Company is committed to

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye